×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Faculty of Healt... [2]
Authors
ZHAO QI [2]
KWOK HANG FAI [1]
Document Type
Journal article [2]
Date Issued
2024 [1]
2022 [1]
Language
英語English [2]
Source Publication
Advanced Science [1]
Journal of Nanob... [1]
Indexed By
SCIE [2]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-2 of 2
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Journal Impact Factor Ascending
Journal Impact Factor Descending
Issue Date Ascending
Issue Date Descending
Submit date Ascending
Submit date Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
Metal-Coordinated NIR-II Nanoadjuvants with Nanobody Conjugation for Potentiating Immunotherapy by Tumor Metabolism Reprogramming
Journal article
Dai, Yeneng, Guo, Ziang, Leng, Dongliang, Jiao, Guanda, Chen, Kai, Fu, Mingxuan, Liu, Yang, Shen, Qingming, Wang, Qi, Zhu, Lipeng, Zhao, Qi. Metal-Coordinated NIR-II Nanoadjuvants with Nanobody Conjugation for Potentiating Immunotherapy by Tumor Metabolism Reprogramming[J]. Advanced Science, 2024, 11(34), 2404886.
Authors:
Dai, Yeneng
;
Guo, Ziang
;
Leng, Dongliang
;
Jiao, Guanda
;
Chen, Kai
; et al.
Favorite
|
TC[WOS]:
7
TC[Scopus]:
4
IF:
14.3
/
16.3
|
Submit date:2024/08/05
Amplified Immunotherapy
Lactate Efflux
Nanoadjuvants
Nanobody
Nir-ii Phototheranostics
Synergistic combination of targeted nano-nuclear-reactors and anti-PD-L1 nanobodies evokes persistent T cell immune activation for cancer immunotherapy
Journal article
Zhu, Lipeng, Li, Junnan, Guo, Ziang, Kwok, Hang Fai, Zhao, Qi. Synergistic combination of targeted nano-nuclear-reactors and anti-PD-L1 nanobodies evokes persistent T cell immune activation for cancer immunotherapy[J]. Journal of Nanobiotechnology, 2022, 20(1), 521.
Authors:
Zhu, Lipeng
;
Li, Junnan
;
Guo, Ziang
;
Kwok, Hang Fai
;
Zhao, Qi
Favorite
|
TC[WOS]:
12
TC[Scopus]:
15
IF:
10.6
/
11.4
|
Submit date:2023/01/30
Anti-pd-l1 Nanobody
Hypoxia Modulation
Immune-cold Tumors
Immunogenic Cell Death
Nano-nuclear-reactor
t Cell Immune Activation